Antihyperlipidemic effects of stilbenoids isolated from Morus alba in rats fed a high-cholesterol diet

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 213-218

  Jo, Sung Pil ^a   Kim, Jeong Keun ^b   Lim, Young Hee ^a,c  

^a Korea University   (South Korea)

^b Korea Polytechnic University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Antihyperlipidemic activity; Atherogenic index; High cholesterol diet; Stilbenoids

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MULBERROSIDE A; MULBERRY EXTRACT; OXYRESVERATROL; SIMVASTATIN; STILBENOID DERIVATIVE; TYLOXAPOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERLIPIDEMIC EFFECT; ARTICLE; ATHEROGENIC INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY RISK INDEX; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG PURIFICATION; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIVER FATTY DEGENERATION; MALE; MORUS ALBA; NONHUMAN; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIHYPERLIPIDEMIC ACTIVITY; ATHEROGENIC INDEX; HIGH-CHOLESTEROL DIET; STILBENOIDS;

ANIMALS; BODY WEIGHT; CHOLESTEROL, DIETARY; DISACCHARIDES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MORUS; PLANT EXTRACTS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84892889356     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.040     Document Type: Article

References (28)

1. Abbott R.D., Wilson P.W., Kannel W.B., Castelli W.P. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988, 8:207-211.
2. Adeneye A.A., Adeyemi O.O., Agbaje E.O. Anti-obesity and antihyperlipidaemic effect of Hunteria umbellata seed extract in experimental hyperlipidaemia. J. Ethnopharmacol. 2010, 130:307-314.
3. Anderson J.W., Baird P., Davis R.H., Ferreri S., Knudtson M., Koraym A., Waters V., Williams C.L. Health benefits of dietary fiber. Nutr. Rev. 2009, 67:188-205.
4. Arai Y., Watanabe S., Kimira M., Shimoi K., Mochizuki R., Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 2000, 130:2243-2250.
5. Ballantyne C.M. Treatment of dyslipidemia to reduce cardiovascular risk in patients with multiple risk factors. Clin. Cornerstone 2007, 8(Suppl. 6):S6-13.
6. Beltowski J., Wojcicka G., Jamroz-Wisniewska A. Adverse effects of statins - mechanisms and consequences. Curr. Drug Saf. 2009, 4:209-228.
7. Chao J., Yu M.S., Ho Y.S., Wang M., Chang R.C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med. 2008, 45:1019-1026.
8. Chen Q., Wang E., Ma L., Zhai P. Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice. Lipids Health Dis. 2012, 11:56.
9. El-Beshbishy H.A., Singab A.N., Sinkkonen J., Pihlaja K. Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci. 2006, 78:2724-2733.
10. Fernandes R., Shaikh I., Wegstapel H. Possible association between statin use and bowel dysmotility. BMJ Case Rep. 2012, 2012. 10.1136/bcr.10.2011.4918.
11. Fki I., Bouaziz M., Sahnoun Z., Sayadi S. Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet. Bioorg. Med. Chem. 2005, 13:5362-5370.
12. Fodor, J.G., Frohlich, J.J., Genest Jr., J.J., McPherson, P.R., 2000. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ 162, pp. 1441-1447.
13. Friedman M., Byers S.O. Mechanism underlying hypercholesteremia induced by triton WR-1339. Am. J. Physiol. 1957, 190:439-445.
14. Garattini S., Morpurgo C., Murelli B., Paoletti R., Passerini N. The effect of triton and diphenylylethylacetic acid on cholesterol and fatty acid biosynthesis in isolated perfused liver. Experientia 1959, 15:33-34.
15. Gotto A.M. Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F, Bishop Lecture. J. Am. Coll. Cardiol. 2005, 46:1219-1224.
16. Han L.K., Sumiyoshi M., Zhang J., Liu M.X., Zhang X.F., Zheng Y.N., Okuda H., Kimura Y. Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals. Phytother. Res. 2003, 17:1188-1194.
17. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk 1996, 3:213-219.
18. Hsu C.L., Yen G.C. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br. J. Nutr. 2007, 98:727-735.
19. Hsu C.L., Wu C.H., Huang S.L., Yen G.C. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J. Agric. Food Chem. 2009, 57:425-431.
20. Kellner A., Correll J.W., Ladd A.T. Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents. J. Exp. Med. 1951, 93:373-384.
21. Kim J.K., Kim M., Cho S.G., Kim M.K., Kim S.W., Lim Y.H. Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. J. Ind. Microbiol. Biotechnol. 2010, 37:631-637.
22. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., Horn T.F. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 2003, 9:64-76.
23. Park K.M., You J.S., Lee H.Y., Baek N.I., Hwang J.K. Kuwanon G: an antibacterial agent from the root bark of Morus alba against oral pathogens. J. Ethnopharmacol. 2003, 84:181-185.
24. Parker B.A., Thompson P.D. Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes. Exerc. Sport Sci. Rev. 2012, 40:188-194.
25. Raederstorff D.G., Schlachter M.F., Elste V., Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 2003, 14:326-332.
26. Sewright K.A., Clarkson P.M., Thompson P.D. Statin myopathy: incidence, risk factors, and pathophysiology. Curr. Atheroscler. Rep. 2007, 9:389-396.
27. Tamasi G., Borsy J., Patthy A. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats. Biochem. Pharmacol. 1968, 17:1789-1794.
28. Venkatesh K.R., Seema C. Mulberry: life enhancer. J. Med. Plant. Res. 2008, 2:271-278.